Black Diamond Therapeutics, Inc. BDTX
- BDTX-4876 Preclinical
FGFR2 (3 companies · 3 programs)
Companies with an active program directed at FGFR2.
Relay Therapeutics, Inc. RLAY
- LYRFIGTU — Cholangiocarcinoma Approved
Tyra Biosciences, Inc. TYRA
- TYRA-200 — Intrahepatic Cholangiocarcinoma Phase 1